Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma-Reference-Cited by-同舟云学术

Clinicopathological and prognostic values of ErbB receptor family amplification in primary osteosarcoma

Published:2019-10-30 Issue:8 Volume:79 Page:601-612
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Huang Zhen¹,Wang Sheng-Lin¹,Chen Hui²,Shen Rong-Kai¹,Li Xiao-Dong¹,Huang Qing-Shan¹,Wu Chao-Yang¹,Weng Dan-Feng³,Lin Jian-Hua¹⁴

Affiliation:

1. Department of Orthopedics, the First Affiliated Hospital of Fujian Medical University, Fuzhou, P.R. China;

2. Department of Nephrology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, P.R. China;

3. Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, P.R. China;

4. Fujian Provincial Institute of Orthopedics, the First Affiliated Hospital of Fujian Medical University, Fuzhou, P.R. China

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

Reference45 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas;American Society of Clinical Oncology Educational Book;2023-05

5. Regulation of Molecular Targets in Osteosarcoma Treatment;International Journal of Molecular Sciences;2022-10-20